Iridian Asset Management’s Elevance Health ELV Stock Holding History

Iridian Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9,900	Closed	-$4.86M	–	54
2022 Q1	$4.86M	Buy	9,900 +400	+4%	+$183K	0.34%	42
2021 Q4	$4.4M	Hold	9,500	–	–	0.27%	48
2021 Q3	$3.54M	Hold	9,500	–	–	0.11%	53
2021 Q2	$3.63M	Hold	9,500	–	–	0.06%	57
2021 Q1	$3.41M	Hold	9,500	–	–	0.06%	64
2020 Q4	$3.05M	Buy	9,500 +4,500	+90%	+$1.38M	0.06%	59
2020 Q3	$1.34M	Buy	+5,000	New	+$1.35M	0.03%	59

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Iridian Asset Management's ELV Position: Q1 2026 in Review

Iridian Asset Management reduced its Elevance Health (ELV) stake by 14% in Q1 2026, selling an estimated $1.13M and leaving 21,625 shares worth $6.33M. The position accounts for 2.57% of the portfolio, ranked #12.

Iridian Asset Management first reported a position in ELV in Q2 2018 and has held it in 32 quarters since. The position peaked at $430M in Q3 2018. 1,463 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Iridian Asset Management held 21,625 shares of Elevance Health worth $6.33M as of Q1 2026.
Iridian Asset Management sold 3,449 Elevance Health shares in Q1 2026, an estimated $1.13M.
Elevance Health made up 2.57% of Iridian Asset Management's portfolio in Q1 2026, its #12 holding.
Iridian Asset Management first reported a position in Elevance Health in Q2 2018 and has held it in 32 quarters since.
Iridian Asset Management's Elevance Health position peaked at $430M in Q3 2018.
1,463 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Iridian Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.